1CoUison LW, Workman C J, Kuo TY, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function[ J]. Nature, 2007,450 (7169) : 566 -569.
2Devergne O, Hummel M, Koeppen H, et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes[J]. J Virol, 1996, 70(2) : 1143 -1153.
3Devergne O, Birkenbach M, Kieff E. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel hetemdimefic hematopoietin[ J]. Proe Nail Acad Sci U S A, 1997, 94(22) : 12041 - 12046.
4Liu F, Tong F, He Y, et al. Detectable expression of IL-35 in CIM + T cells from peripheral blood of chronic hepatitis B patients[ J]. Clin Immunol, 2011, 139(1): 1-5.
5Kempe S, Heinz P, Kokai E, et al. Epstein-barr virus-induced gene- 3 is expressed in human atheroma plaques [ J ]. Am J Pathol, 2009, 175(1) : 440 -447.
6Bardel E, Larousserie F, Charlot-Rabiega P, et al. Human CD4 + CD25 + Foxp3 + regulatory T cells do not constitutively express IL-35 [J]. J Immunol, 2008, 181(10) : 6898 -6905.
7Chaturvedi V, Collison LW, Guy CS, et al. Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance[ J]. J Immunol, 2011, 186(12) : 6661 -6666.
8Seyerl M, Kirchberger S, Majdic O, et al. Human rhinovimses induce IL-35-producing Tregvialnduction of B7-H1 ( CD274 ) and sialoadhe- sin (CD169) on DC[J]. EurJ Immunol, 2010, 40(2) : 321 -329.
9Niedbala W, Wei XQ, Cai B, et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expan- sion of regulatory T ceils and suppression of Thl7 cells[ J]. Eur J Im- munol, 2007, 37(11): 3021 -3029.
10Collison LW, Chaturvedi V, Henderson AL, et al. IL-35-mediated induction of a potent regulatory T cell population[ J]. Nat Immunol, 2010, 11(12) : 1093 -1101.
3RICHARDSON P, MCKENNA W, BRISTOW M, et al. Report of the 1995 world health organization/international society and federation of cardiology taskforce on the definition and classification of cardiomyopathies [J]. Circulation, 1996, 93:841-- 842.
4NIEDBALA W, WEI X Q, CAI B, et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells [J]. Eur J Immunol, 2007, 37:3021--3029.
5YANG J, YANG M, HTUT TM, et al. Epstein- Barr virus-induced gene 3 negatively regulates IL-17, Iil-22 and RORγt [J]. Eur J Immunol, 2008, 38: 1204--1214.
6COLLISON L W, WORKMAN C J, KUO T T, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function [J]. Nature, 2007, 450:566--569.
7NIEUWENHUIS E E, NEURATH M F, CORAZZA N, et al. Disruption of T helper 2-immune responses in Epstien Barr virus-induced gene 3-deficient mice [J].Proc Natl Acad Sci U S A, 2002, 99..16951-- 16956.
8REDDY J, LLLES Z, ZHANG X, et al. Myelin proteolipid protein-special CD4^+ CD25^+ regulatory ceils mediate genetic resistance to experimental autoimmune encephalomyelitis [J].Proe Natl Aead Sci U S A, 2004, 101:15434--15439.
9COLLISON L W, VIGNALI D A. Interleukin-35: odd one out or part of the family? [J]. Immunol Rev, 2008, 226:248--262.
10DEVERGNE O, BIRKENBACH M, KIEFF E. Epstein-Barr virus-induced gene 3 and p35 subunit of interleukin 12 from a novel heterodimeric hematopoietin [J]. Proc Natl Acad Sci U S A, 1997, 94:12041-- 12046.
